Entasis Therapeutics Holdings Inc. - Price History
Stock symbol ETTX is outdated, potentially delisted? Maybe it is available on other exchange?
Monthly price history for ETTX (Entasis Therapeutics Holdings Inc.)
Date | Adjusted price | Real price |
---|---|---|
May 2024 | $2.19 | $2.19 |
May 2023 | $2.19 | $2.19 |
April 2023 | $2.19 | $2.19 |
March 2023 | $2.19 | $2.19 |
February 2023 | $2.19 | $2.19 |
January 2023 | $2.19 | $2.19 |
December 2022 | $2.19 | $2.19 |
November 2022 | $2.19 | $2.19 |
October 2022 | $2.19 | $2.19 |
September 2022 | $2.19 | $2.19 |
August 2022 | $2.19 | $2.19 |
July 2022 | $2.19 | $2.19 |
June 2022 | $2.20 | $2.20 |
May 2022 | $2.18 | $2.18 |
April 2022 | $1.88 | $1.88 |
March 2022 | $1.87 | $1.87 |
February 2022 | $1.70 | $1.70 |
January 2022 | $1.47 | $1.47 |
December 2021 | $2.19 | $2.19 |
November 2021 | $2.58 | $2.58 |
October 2021 | $2.85 | $2.85 |
September 2021 | $3.34 | $3.34 |
August 2021 | $2.79 | $2.79 |
July 2021 | $2.27 | $2.27 |
June 2021 | $2.67 | $2.67 |
May 2021 | $2.37 | $2.37 |
April 2021 | $2.10 | $2.10 |
March 2021 | $2.14 | $2.14 |
February 2021 | $2.66 | $2.66 |
January 2021 | $3.15 | $3.15 |
December 2020 | $2.47 | $2.47 |
November 2020 | $1.84 | $1.84 |
October 2020 | $1.61 | $1.61 |
September 2020 | $2.04 | $2.04 |
August 2020 | $2.65 | $2.65 |
July 2020 | $2.80 | $2.80 |
June 2020 | $2.96 | $2.96 |
May 2020 | $2.77 | $2.77 |
April 2020 | $2.76 | $2.76 |
March 2020 | $2.64 | $2.64 |
February 2020 | $5.27 | $5.27 |
January 2020 | $5 | $5 |
December 2019 | $4.97 | $4.97 |
November 2019 | $4.85 | $4.85 |
October 2019 | $5.97 | $5.97 |
September 2019 | $5.96 | $5.96 |
August 2019 | $7.40 | $7.40 |
July 2019 | $6.55 | $6.55 |
June 2019 | $6.45 | $6.45 |
May 2019 | $6.15 | $6.15 |
April 2019 | $6.88 | $6.88 |
March 2019 | $6.76 | $6.76 |
February 2019 | $5.80 | $5.80 |
January 2019 | $5.26 | $5.26 |
December 2018 | $4.07 | $4.07 |
November 2018 | $6.14 | $6.14 |
October 2018 | $6.11 | $6.11 |
September 2018 | $10.88 | $10.88 |
ETTX
Price: $2.19
52 week price:
Earnings Per Share: -1.45 USD
P/E Ratio: -0.51
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 53541
Market Capitalization: 104.3 million